HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Ho Baek Selected Research

4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- trifluoromethylphenyl)- 3- (4- pyrazin- 2- ylpyrimidin- 2- ylamino)benzamide

11/2021Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.
11/2017Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.
6/2017Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells.
10/2016Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
1/2015Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Ho Baek Research Topics

Disease

19Neoplasms (Cancer)
04/2022 - 06/2004
13Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2005
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 01/2005
4Acute Promyelocytic Leukemia
10/2018 - 11/2010
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 06/2005
4Leukemia
05/2008 - 06/2004
3Colonic Neoplasms (Colon Cancer)
04/2022 - 07/2021
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2007
3Rectal Neoplasms (Rectal Cancer)
06/2021 - 11/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2015 - 04/2008
3Disease Progression
11/2012 - 06/2005
3Bronchiolitis Obliterans Syndrome
02/2006 - 06/2004
2Febrile Neutropenia
01/2017 - 03/2006
2Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2016 - 12/2004
2Adenocarcinoma
06/2015 - 12/2005
2Pain (Aches)
10/2014 - 12/2013
2Cancer Pain
10/2014 - 12/2013
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2010 - 02/2009
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
07/2006 - 02/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2005 - 06/2005
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2022
1Hypothyroidism
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Vitamin D Deficiency
07/2021
1Hemorrhage
01/2021
1Fibrosis (Cirrhosis)
10/2018
1Ascites
01/2018
1Neutropenia
01/2018
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2017
1Pleural Effusion (Pleural Effusions)
06/2016
1Prostatic Neoplasms (Prostate Cancer)
06/2016
1Chylothorax
06/2016
1Nausea
02/2016
1Vomiting
02/2016
1Breakthrough Pain
10/2014

Drug/Important Bio-Agent (IBA)

9Cisplatin (Platino)FDA LinkGeneric
06/2015 - 12/2005
54- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- trifluoromethylphenyl)- 3- (4- pyrazin- 2- ylpyrimidin- 2- ylamino)benzamideIBA
11/2021 - 01/2015
5Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2021 - 06/2007
5GemcitabineFDA Link
01/2017 - 07/2006
4Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 12/2005
4Tyrosine Kinase InhibitorsIBA
06/2017 - 11/2010
4Docetaxel (Taxotere)FDA Link
06/2015 - 01/2005
3Etoposide (VP 16)FDA LinkGeneric
07/2006 - 12/2004
2Dasatinib (BMS 354825)FDA Link
11/2021 - 11/2017
2bcr-abl Fusion ProteinsIBA
11/2017 - 01/2015
2EnzymesIBA
01/2017 - 06/2005
2Biological ProductsIBA
01/2015 - 06/2012
2Arsenic Trioxide (Trisenox)FDA Link
06/2012 - 11/2010
2Imatinib Mesylate (Gleevec)FDA Link
04/2012 - 02/2006
2Irinotecan (Camptosar)FDA LinkGeneric
01/2008 - 12/2005
2Fluorouracil (Carac)FDA LinkGeneric
06/2007 - 03/2006
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2007 - 10/2005
2Prednisone (Sone)FDA LinkGeneric
07/2006 - 12/2004
2Vincristine (Oncovin)FDA LinkGeneric
07/2006 - 12/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2006 - 12/2004
2Epirubicin (Ellence)FDA LinkGeneric
03/2006 - 12/2004
1tislelizumabIBA
01/2022
1GTP Phosphohydrolases (GTPases)IBA
01/2022
1NivolumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1Vitamin DFDA LinkGeneric
07/2021
1AnticoagulantsIBA
01/2021
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2021
1Tight Junction ProteinsIBA
12/2019
1AntioxidantsIBA
10/2018
1rheinIBA
10/2018
1Alkaline PhosphataseIBA
01/2018
1AlbuminsIBA
01/2018
1RamucirumabIBA
01/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2016
1AndrogensIBA
06/2016
1Serotonin (5 Hydroxytryptamine)IBA
02/2016
1Palonosetron (Aloxi)FDA Link
02/2016
1Granisetron (Kytril)FDA LinkGeneric
02/2016
1AcidsIBA
01/2015
1caffeic acidIBA
01/2015
1Rosmarinic AcidIBA
01/2015
1EstersIBA
01/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2015
1Therapeutic UsesIBA
01/2015
1Hydromorphone (Dilaudid)FDA LinkGeneric
10/2014
1Opioid Analgesics (Opioids)IBA
10/2014
1Oxycodone (Oxycontin)FDA LinkGeneric
12/2013

Therapy/Procedure

14Drug Therapy (Chemotherapy)
01/2022 - 12/2005
7Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 12/2005
6Therapeutics
01/2022 - 01/2007
4Adjuvant Chemotherapy
04/2022 - 03/2006
3Stem Cell Transplantation
02/2006 - 06/2004
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2005 - 06/2004
2Neoadjuvant Therapy
07/2020 - 11/2019
2Salvage Therapy
06/2016 - 10/2005
2Transplantation
01/2005 - 06/2004
1Consolidation Chemotherapy
06/2021
1Radiotherapy
06/2021
1Chemoradiotherapy
11/2019
1Pain Management
12/2013